Delivery Order SPE2DR25D9239-SPE2DR26FFCH7
Award Date 3/10/26
Potential Completion Date 3/31/26
Potential Value $3.1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, for Ozurdex 0.7 mg implants, with a ceiling value of $2,050.84. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. This delivery order is issued under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a single-award indefinite delivery contract with a $499.999 billion ceiling and ultimate completion...
- The Defense Logistics Agency issued a $5,127.05 delivery order to DMS Pharmaceutical Group Inc. on March 6, 2026, for OZURDEX 0.7 mg implants under its Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. Place of performance is Park Ridge, IL. The order has a firm fixed price and an ultimate completion date of March 27, 2026. The parent PPV-G GEN V contract,...
- The Defense Logistics Agency awarded a $4,101.68 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for OZURDEX 0.7 mg implants, effective January 21, 2026, with an ultimate completion date of February 11, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,016.14 to DMS Pharmaceutical Group Inc. on September 10, 2025, for the supply of Ozurdex 0.7 mg implants. This firm fixed-price delivery order, which carries an ultimate completion date of October 1, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program. The delivery order does not utilize a set-aside designation and will be performed at the contractor's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,003.02 contract is for the supply of Ozurdex 0.7 mg implants, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. The IDC allows the DLA...
- The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $4,021.56 to DMS Pharmaceutical Group Inc. for OZURDEX 0.7 mg implants on October 16, 2025. OZURDEX is a sustained-release dexamethasone implant used in ophthalmic applications for treating inflammation and macular edema. The award was issued under a firm fixed-price delivery order contract with no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,003.02 contract is for the delivery of OZURDEX 0.7 MG IMPLANTS, a pharmaceutical product, with a completion date of March 4, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense Logistics Agency for the supply of a broad...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $2,010.76 for OZURDEX 0.7 mg implants on June 18, 2025. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The contract carries no set-aside designation...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,004.53, is for the delivery of OZURDEX 0.7 MG IMPLANTS to support the recurring pharmaceutical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
- The Defense Logistics Agency, a combat logistics support agency within the Department of Defense, awarded a $2,925.87 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for 0.7 mg OZURDEX implants. The contract has a period of performance from August 1, 2023 through August 22, 2023, with all work to be performed by DMS Pharmaceutical Group Inc. at its facility located in Park Ridge, Illinois. No additional details were provided regarding the original solicitation or whether this...